These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38341124)
1. Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis. Chen D; Zeng S; Qiu H; Yang M; Lin X; Lv X; Li P; Weng S; Kou S; Luo K; Liu Z; Yi Y; Liu H Cell Signal; 2024 May; 117():111079. PubMed ID: 38341124 [TBL] [Abstract][Full Text] [Related]
2. The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer. Ren J; Chen W; Zhou Y; Sun J; Jiang G BMC Cancer; 2024 Mar; 24(1):278. PubMed ID: 38429642 [TBL] [Abstract][Full Text] [Related]
3. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis. Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors. Darbeheshti F; Mansoori Y; Azizi-Tabesh G; Zolfaghari F; Kadkhoda S; Rasti A; Rezaei N; Shakoori A Biochem Genet; 2023 Aug; 61(4):1487-1508. PubMed ID: 36645554 [TBL] [Abstract][Full Text] [Related]
5. Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis. Shao G; Fan X; Zhang P; Liu X; Huang L; Ji S Cell Biol Toxicol; 2023 Oct; 39(5):2183-2205. PubMed ID: 35870038 [TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448. Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis. Huang Y; Zheng S; Lin Y; Ke L Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552 [TBL] [Abstract][Full Text] [Related]
8. Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis. Wang Z; Li Y; Yang J; Liang Y; Wang X; Zhang N; Kong X; Chen B; Wang L; Zhao W; Yang Q Cell Death Dis; 2022 Sep; 13(9):776. PubMed ID: 36075896 [TBL] [Abstract][Full Text] [Related]
9. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis. Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960 [TBL] [Abstract][Full Text] [Related]
10. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1. Wang Q; Li Z; Hu Y; Zheng W; Tang W; Zhai C; Gu Z; Tao J; Wang H J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):323-331. PubMed ID: 31776835 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA-associated ceRNA network involved in HIF-1 signalling in triple-negative breast cancer: circ_0047303 as a potential key regulator. Darbeheshti F; Mahdiannasser M; Noroozi Z; Firoozi Z; Mansoori B; Daraei A; Bastami M; Nariman-Saleh-Fam Z; Valipour E; Mansoori Y J Cell Mol Med; 2021 Dec; 25(24):11322-11332. PubMed ID: 34791795 [TBL] [Abstract][Full Text] [Related]
12. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab. Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240 [TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling. Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway. Wang S; Li Q; Wang Y; Li X; Wang R; Kang Y; Xue X; Meng R; Wei Q; Feng X Biochem Biophys Res Commun; 2018 Nov; 505(4):996-1002. PubMed ID: 30314706 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA hsa_circ_0001368 suppresses the progression of gastric cancer by regulating miR-6506-5p/FOXO3 axis. Lu J; Zhang PY; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Huang CM; Zheng CH Biochem Biophys Res Commun; 2019 Apr; 512(1):29-33. PubMed ID: 30853185 [TBL] [Abstract][Full Text] [Related]
16. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression. Zou Y; Zheng S; Xiao W; Xie X; Yang A; Gao G; Xiong Z; Xue Z; Tang H; Xie X Carcinogenesis; 2019 Dec; 40(12):1469-1479. PubMed ID: 31001629 [TBL] [Abstract][Full Text] [Related]
17. Circ_0041732 regulates tumor properties of triple-negative breast cancer cells by the miR-149-5p/FGF5 pathway. Li H; Yin H; Yan Y Int J Biol Markers; 2022 Jun; 37(2):178-190. PubMed ID: 35341378 [TBL] [Abstract][Full Text] [Related]
18. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway. Li Y; Wang Z; Su P; Liang Y; Li Z; Zhang H; Song X; Han D; Wang X; Liu Y; Yang J; Chen B; Wang L; Zhao W; Yang Q Mol Ther; 2022 Jan; 30(1):415-430. PubMed ID: 34450253 [TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit. Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486 [TBL] [Abstract][Full Text] [Related]
20. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway. Xie R; Tang J; Zhu X; Jiang H Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827 [No Abstract] [Full Text] [Related] [Next] [New Search]